Cardlytics, Inc. (CDLX)

NASDAQ:
CDLX
| Latest update: Dec 9, 2025, 1:37 PM

Stock events for Cardlytics, Inc. (CDLX)

Cardlytics' stock price has declined significantly over the past year. Key events include the Q3 2025 financial results, which reported a decrease in total billings and revenue due to content restrictions. Workforce reductions were announced as a cost-saving initiative. Q2 2025 revenue and billings also decreased year-over-year, but adjusted EBITDA was positive. New customer insights dashboards were introduced. Q1 2025 results met or exceeded guidance despite a seasonally weak quarter.

Demand Seasonality affecting Cardlytics, Inc.’s stock price

Cardlytics experiences seasonality in its demand, with the first quarter generally being a seasonally weak quarter. Consumer spending patterns also influence demand, with a notable decrease in the multiline retail category during the holiday season in Q4. The company anticipates some variability in its quarter-to-quarter results.

Overview of Cardlytics, Inc.’s business

Cardlytics, Inc. operates as a commerce media platform connecting marketers with consumers through digital channels, leveraging anonymized, real-time purchase data to deliver targeted advertising campaigns within banking applications. The company's major products include the Cardlytics Platform, a native bank advertising channel, and the Bridg Platform, a customer data platform utilizing point-of-sale data.

CDLX’s Geographic footprint

Cardlytics, Inc. operates in the United States and the United Kingdom, with its headquarters in Atlanta, Georgia. It also has offices in Menlo Park, Los Angeles, Champaign, New York, London, and Taipei City.

CDLX Corporate Image Assessment

Cardlytics was named the "Best Digital Ad Network in 2025" and experienced growth in its user base. However, the company has faced financial challenges, including revenue contraction and missed quarterly targets. Workforce reductions could be perceived negatively by some stakeholders.

Ownership

Cardlytics, Inc. exhibits a mixed ownership structure with institutional shareholders, Cardlytics insiders, and retail investors holding significant portions of the company's stock. CAS Investment Partners, LLC is the largest single institutional holder. The largest individual shareholder is Clifford Sosin.

Expert AI

Show me the sentiment for Cardlytics, Inc.
What's the latest sentiment for Cardlytics, Inc.?

Price Chart

$1.10

21.99%
(1 month)

Top Shareholders

CAS Investment Partners LLC
10.23%
The Vanguard Group, Inc.
4.75%
Bank of America Corp.
3.21%
KPS Global Asset Management UK Ltd.
2.40%
683 Capital Management LLC
2.31%
Worldly Partners Management LLC
2.28%
Mirabella Group Holdings Ltd.
2.27%
Quinn Opportunity Partners LLC
2.16%

Trade Ideas for CDLX

Today

Sentiment for CDLX

News
Social

Buzz Talk for CDLX

Today

Social Media

FAQ

What is the current stock price of Cardlytics, Inc.?

As of the latest update, Cardlytics, Inc.'s stock is trading at $1.10 per share.

What’s happening with Cardlytics, Inc. stock today?

Today, Cardlytics, Inc. stock is down by -21.99%, possibly due to news.

What is the market sentiment around Cardlytics, Inc. stock?

Current sentiment around Cardlytics, Inc. stock is negative, based on recent news, trading volume, and analyst opinions.

Is Cardlytics, Inc.'s stock price growing?

Over the past month, Cardlytics, Inc.'s stock price has decreased by -21.99%.

How can I buy Cardlytics, Inc. stock?

You can buy Cardlytics, Inc. stock through any brokerage platform, such as e.g., Robinhood, Fidelity, E*TRADE, by searching for the ticker symbol CDLX

Who are the major shareholders of Cardlytics, Inc. stock?

Major shareholders of Cardlytics, Inc. include institutions such as CAS Investment Partners LLC (10.23%), The Vanguard Group, Inc. (4.75%), Bank of America Corp. (3.21%) ... , according to the latest filings.